{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"columns":[{"gene":"","key":"MONDO:0018613/ORPHA:442582","label":"AH amyloidosis","mondoId":"MONDO:0018613","onsetQualifier":null,"recordKeys":["29994e0f57b5269b298675955c6abc9277509b6b79029f8f143b30f7daf5311e","5132341e524383edf94eb034aa6622ab45869ba5667cae98ccb6cc0b82068da6","64661ba21f82c7df9e439978a915838df8f452a011cd69e21729bb48aacca867","7c42d29a809e1ad6c83464a767aad6ddb18accc7ffe69108a09c6d8f72accf66","ba7e434d3ef0d1ead057a8799c0b70a6243c5301a4a55a2ce4f606d38763ae0a","d09d0b20233e6053cb94c74862beea3327719877b299ec5f4f9cd1abeddeaed1","de157f226f89300f423eead75397d67374ca29595e723fa1ceaf8620e93ad22a","e5fccf2aa6e704071a20226c1803c88003e5deaebee0c984bfb70d203a0d60a2"],"recordQualifiers":{},"scopeLabel":"ORPHA:442582","sourceIds":["ORPHA:442582"],"sourceScope":"This column retains the native source entry. It is not a pooled estimate for the umbrella condition."}],"comparison":{"collapseColumnsLabel":"Show initial comparisons","defaultColumnKeys":["MONDO:0018613/ORPHA:442582"],"expandColumnsLabel":"Compare all source entries","intro":"Compare the original source entries. Different entries may describe different patient groups.","primaryFeatureIds":[],"scopeNoteHtml":"<p>Each column keeps its native condition scope. Initial features are displayed alphabetically, not ranked by clinical importance. Counts remain separate, and an empty cell does not mean a feature cannot occur.</p>"},"coverage":{"countRecords":0,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":8,"sourceGroups":{"omim":0,"orphanet":8,"published":0}},"features":[{"hpoId":"HP:0100292","label":"Amyloidosis of peripheral nerves","primary":false},{"hpoId":"HP:0030843","label":"Cardiac amyloidosis","primary":false},{"hpoId":"HP:0031185","label":"Elevated circulating NT-proBNP concentration","primary":false},{"hpoId":"HP:0000853","label":"Goiter","primary":false},{"hpoId":"HP:0000112","label":"Nephropathy","primary":false},{"hpoId":"HP:0031047","label":"Paraproteinemia","primary":false},{"hpoId":"HP:0009830","label":"Peripheral neuropathy","primary":false},{"hpoId":"HP:0001917","label":"Renal amyloidosis","primary":false}],"ledeHtml":"A patient-friendly description is not yet available in the ingested narrative sources for this condition.","mondoId":"MONDO:0018613","records":[{"frequencyKind":"range","key":"29994e0f57b5269b298675955c6abc9277509b6b79029f8f143b30f7daf5311e","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:442582","disease_name":"AH amyloidosis","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0030843","is_excluded":false,"label":"Cardiac amyloidosis","onset_id":null,"reference":"ORPHA:442582","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"5132341e524383edf94eb034aa6622ab45869ba5667cae98ccb6cc0b82068da6","raw":{"aspect":"P","body_system":"immune","disease_id":"ORPHA:442582","disease_name":"AH amyloidosis","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0031047","is_excluded":false,"label":"Paraproteinemia","onset_id":null,"reference":"ORPHA:442582","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"64661ba21f82c7df9e439978a915838df8f452a011cd69e21729bb48aacca867","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:442582","disease_name":"AH amyloidosis","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0031185","is_excluded":false,"label":"Elevated circulating NT-proBNP concentration","onset_id":null,"reference":"ORPHA:442582","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"7c42d29a809e1ad6c83464a767aad6ddb18accc7ffe69108a09c6d8f72accf66","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:442582","disease_name":"AH amyloidosis","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001917","is_excluded":false,"label":"Renal amyloidosis","onset_id":null,"reference":"ORPHA:442582","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"ba7e434d3ef0d1ead057a8799c0b70a6243c5301a4a55a2ce4f606d38763ae0a","raw":{"aspect":"P","body_system":"endocrine","disease_id":"ORPHA:442582","disease_name":"AH amyloidosis","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0000853","is_excluded":false,"label":"Goiter","onset_id":null,"reference":"ORPHA:442582","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"d09d0b20233e6053cb94c74862beea3327719877b299ec5f4f9cd1abeddeaed1","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:442582","disease_name":"AH amyloidosis","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0009830","is_excluded":false,"label":"Peripheral neuropathy","onset_id":null,"reference":"ORPHA:442582","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"de157f226f89300f423eead75397d67374ca29595e723fa1ceaf8620e93ad22a","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:442582","disease_name":"AH amyloidosis","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0100292","is_excluded":false,"label":"Amyloidosis of peripheral nerves","onset_id":null,"reference":"ORPHA:442582","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"e5fccf2aa6e704071a20226c1803c88003e5deaebee0c984bfb70d203a0d60a2","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"ORPHA:442582","disease_name":"AH amyloidosis","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0000112","is_excluded":false,"label":"Nephropathy","onset_id":null,"reference":"ORPHA:442582","source_release":"2026-06-23"},"sourceGroups":["orphanet"]}],"referenceLabels":{},"references":{"causeHtml":"<p>No mapped MedlinePlus condition document in this snapshot.</p>","identityNote":"MONDO defines condition identity and route membership. Native evidence populations and narrative coverage retain their separate scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>No MedlinePlus narrative has been mapped to this MONDO condition. Feature annotations, when available, are retained below.</p>","key":"overview","title":"Condition overview"}],"sharedSources":[],"slug":"ah-amyloidosis","sourceDocuments":[],"sourceNote":"MONDO condition identity; scoped MedlinePlus enrichment where available; original HPO annotations.","takeawayHtml":"Cause information is not available in the mapped narrative sources for this condition.","title":"AH amyloidosis"},"schemaVersion":1}